Dosage form: tablet, coated
Drug classes:Hormones / antineoplastics, Selective estrogen receptor modulators
Medically reviewed by Drugs.com. Last updated on Jan 1, 2022.
On This Page
- Boxed Warning
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Drug Interactions
- Use In Specific Populations
- Overdosage
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- How Supplied/Storage and Handling
- Patient Counseling Information
WARNING: INCREASED RISK OF VENOUS THROMBOEMBOLISM AND DEATH FROM STROKE
- Increased risk of deep vein thrombosis and pulmonary embolism have been reported with Raloxifene Hydrochloride Tablets [see Warnings and Precautions (5.1)]. Women with active or past history of venous thromboembolism should not take Raloxifene Hydrochloride Tablets [see Contraindications (4.1)].
- Increased risk of death due to stroke occurred in a trial in postmenopausal women with documented coronary heart...